Important note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date.
 |
The New York Times - July 16, 2005
In an interview with the Brazilian daily Correio Braziliense, Jose Saraiva Felipe, who was sworn in as health minister July 8, the day the deal was made public, said that the agreement had not been signed and that the government was still negotiating with Abbott to get further reductions in the price of the drug, a widely used antiretroviral called Kaletra.
A spokeswoman for the health ministry confirmed Felipe's remarks but declined to comment further.
Michelle Johnson, a spokeswoman for Abbott, said, "We are continuing to meet with the Brazilian government to finalize the agreement."
The government and Abbott announced an agreement July 8 that would freeze the annual amount Brazil pays for Kaletra over the next six years.
050716
NYT050711
Copyright © 2005 - The New York Times Company. All Rights Reserved. All New York Times articles contained on the AEGiS web site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of The New York Times Company. You may not alter or remove any trademark, copyright or other notice from copies of the content. However, you may download articles (one machine readable copy and one print copy per page) for your personal, noncommercial use only.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .